The formation of methemoglobin and sulfhemoglobin during sulfanilamide therapy

[1] ALYEA E. P., 1938, Southern Medical Journal, V31, P395, DOI 10.1097/00007611-193804000-00010

[2] Archer HE, 1937, LANCET, V2, P432

[3] Banks HS, 1938, LANCET, V2, P7

[4] Bensley E H, 1937, Can Med Assoc J, V37, P62

[5] Bensley EH, 1938, Q J MED, V7, P325

[6] Cyanosis without sulf or methemoglobinemia in patients receiving sulfanilamide treatment [J]. JOURNAL OF CLINICAL INVESTIGATION, 1938, 17 (04) : 445 - 447

[7] Clarke TW, 1907, J PHYSIOL-LONDON, V36, P62

[8] Colebrook L, 1937, LANCET, V2, P1237

[9] Colebrook L, 1936, LANCET, V1, P1279

[10] Conant JB, 1932, J BIOL CHEM, V98, P0057

[1] ALYEA E. P., 1938, Southern Medical Journal, V31, P395, DOI 10.1097/00007611-193804000-00010

[2] Archer HE, 1937, LANCET, V2, P432

[3] Banks HS, 1938, LANCET, V2, P7

[4] Bensley E H, 1937, Can Med Assoc J, V37, P62

[5] Bensley EH, 1938, Q J MED, V7, P325

[6] Cyanosis without sulf or methemoglobinemia in patients receiving sulfanilamide treatment [J]. JOURNAL OF CLINICAL INVESTIGATION, 1938, 17 (04) : 445 - 447

[7] Clarke TW, 1907, J PHYSIOL-LONDON, V36, P62

[8] Colebrook L, 1937, LANCET, V2, P1237

[9] Colebrook L, 1936, LANCET, V1, P1279

[10] Conant JB, 1932, J BIOL CHEM, V98, P0057